MORE ANXIOUS NOW? –
Nov. 21, 2024 – The Pennsylvania-based drug maker Endo announced this week that it is expanding its recall of clonazepam tablets because some cartons bear the incorrect drug strength and wrong drug code. The new recall affects 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV), with doses ranging from 0.125 milligrams to 2 milligrams.
The packages feature 10 blister strips that each contain six tablets. They are due to expire between August 2026 and February 2027.
Clonazepam is a benzodiazepine used to treat panic disorder and certain types of seizures.
Endo warns that consuming a higher dose of clonazepam could increase the risk of sleepiness, confusion, dizziness, diminished reflexes and loss of muscle control or strength.
